ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NCI, NIH Hoping 12 Percent Budget Cut Will Not Be Applied To Them

October 2, 1981

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

AACR to honor eight scientists with lecture awards.

February 13, 2004

Tarceva-Induced Rash Strongly Associated With Longer Survival, Sponsor Finds

July 27, 2007

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

September 18, 2009

M.D. Anderson signs collaboration agreement with Institut Gustave Roussy.

February 13, 2004